Zobrazeno 1 - 10
of 326
pro vyhledávání: ''
Autor:
Christopher Sweeney, Eric Winquist, Darren R. Feldman, Ugo De Giorgi, Daniel Y.C. Heng, Silke Gillessen, Michal Chovanec, Jourik A. Gietema, Robert Huddart, Costantine Albany, Fay H. Cafferty, Peter Grimison, Aaron R. Hansen, Carsten Bokemeyer, Karim Fizazi, Jörg Beyer, Christian D. Fankhauser, Nicolas Sauvé, Alexey Tryakin, Torgrim Tandstad, Olof Ståhl, Helene F. S. Negaard, Ronald de Wit, Anja Lorch, Andrea Necchi, David J. Vaughn, Angelika Terbuch, Axel Heidenreich, Cora N. Sternberg, Marcus Hentrich, Xavier Garcia-del-Muro, Gedske Daugaard, Laurence Collette, Jonathan Shamash
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
J Clin Oncol
Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; ... (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), pp. 1563-1574. 10.1200/JCO.20.03296
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), 1563-+. AMER SOC CLINICAL ONCOLOGY
Universidad de Barcelona
J Clin Oncol
Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; ... (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), pp. 1563-1574. 10.1200/JCO.20.03296
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), 1563-+. AMER SOC CLINICAL ONCOLOGY
PURPOSE The classification of the International Germ Cell Cancer Collaborative Group (IGCCCG) plays a pivotal role in the management of metastatic germ cell tumors but relies on data of patients treated between 1975 and 1990. MATERIALS AND METHODS Da
Autor:
Zhihong Chi, Li Zhou, Bin Lian, Bixia Tang, Hong Yao, Jun Guo, Lu Si, Lili Mao, Chuanliang Cui, Xue Bai, Xuan Wang, Siming Li, Xieqiao Yan, Yan Kong, Xinan Sheng, Jie Dai
Publikováno v:
Journal of Clinical Oncology. 39:881-889
PURPOSE Mucosal melanoma (MM) is a highly vascularized tumor with an extremely poor prognosis. In this randomized, open-label, phase II study, we characterized the efficacy and safety of bevacizumab in combination with carboplatin plus paclitaxel (CP
Publikováno v:
J Clin Oncol
PURPOSE Mortality for patients with classical Hodgkin lymphoma (cHL) treated during an era characterized in the United States by widespread use of doxorubicin, bleomycin, vinblastine, and dacarbazine and diminishing use of radiotherapy is not well un
Autor:
Rosa Nadal, Piyush K. Agarwal, Sumanta K. Pal, Biren Saraiya, Howard L. Parnes, Donald P. Bottaro, Daniel Girardi, Vladimir Valera, Mohammad Hadi Bagheri, Lisa Ley, Scot Anthony Niglio, Olena Sierra Ortiz, Seth M. Steinberg, Yangmin M. Ning, Primo N. Lara, William D. Figg, Paul Monk, Heather J. Chalfin, Mark N. Stein, Howard Streicher, Carlos Diaz, Marissa Mallek, Amir Mortazavi, Maria J. Merino, Jacqueline Cadena, Rene Costello, Min-Jung Lee, Jane B. Trepel, William L. Dahut, Nicole N. Davarpanah, James L. Gulley, Andrea B. Apolo, John J. Wright, Jennifer Jones, Lisa M. Cordes
Publikováno v:
Journal of Clinical Oncology
PURPOSE We assessed the safety and efficacy of cabozantinib and nivolumab (CaboNivo) and CaboNivo plus ipilimumab (CaboNivoIpi) in patients with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignances. PATIENTS AND METHODS Pati
Autor:
Shisheng Tan, Sanjun Cai, Ji Zhu, Zhen Zhang, Yaqun Zhu, Hongyan Zhang, Xin Wang, Chen Zhang, Tao Zhang, Jianhui Jia, Jialin Yang, Xinchen Sun, Hui Zhang, Wei Zhang, F. Xia, Juefeng Wan, Yuanyuan Zhao, Anwen Liu, Junxin Wu, Luying Liu, Juying Zhou, Lijun Shen, Gang Cai
Publikováno v:
Journal of Clinical Oncology
PURPOSE Differentiating the irinotecan dose on the basis of the uridine diphosphate glucuronosyltransferase 1A1 ( UGT1A1) genotype improves the pathologic complete response (pCR) rate. In this study, we further investigated preoperative irinotecan co
Autor:
Yu Deng, Mark A. Socinski, Hina Patel, Geetha Shankar, Denis Moro-Sibilot, Martin Früh, Shelley Coleman, Wei Yu, Elisabeth Piault, Martin Reck, Mikhail Shtivelband, T. Wehler, José Luis González Larriba, Carlo Barone, Anthony Lee, Naoyuki Nogami, Jeffrey Rothenstein, Francisco Orlandi, Claudia Kelsch
Publikováno v:
Journal of Clinical Oncology
PURPOSE Atezolizumab, bevacizumab, carboplatin, and paclitaxel (ABCP) demonstrated survival benefit versus bevacizumab, carboplatin, and paclitaxel (BCP) in chemotherapy-naïve nonsquamous non–small-cell lung cancer (NSCLC). We present safety and p
Autor:
Miguel Martin, Vicente Valero, Sara A. Hurvitz, Chiun-Sheng Huang, Daniil Stroyakovskiy, Mario Campone, Vanesa Lopez-Valverde, Peter Trask, Gonzalo Spera, Jean Francois Boileau, Chunyan Song, Peter A. Fasching, W. Fraser Symmans, Kyung Hae Jung, Joseph A. Sparano, Hans Wildiers, Thomas Boulet, Alastair M. Thompson, Karen Afenjar, Nadia Harbeck, Dennis J. Slamon
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 37, iss 25
Journal of Clinical Oncology
Journal of Clinical Oncology
PURPOSE The KRISTINE study compared neoadjuvant trastuzumab emtansine plus pertuzumab (T-DM1+P) with docetaxel, carboplatin, trastuzumab plus P (TCH+P) for the treatment human epidermal growth factor receptor 2–positive stage II to III breast cance
Autor:
Sirpa Leppä, Su-Peng Yeh, Ronit Gurion, Mehmet Turgut, Sriram Balasubramanian, Laurie H. Sehn, Anas Younes, Sen Hong Zhuang, Xiaonan Hong, Pier Luigi Zinzani, Andres Lopez-Hernandez, Shinya Rai, Caterina Patti, S. Martin Shreeve, Wojciech Jurczak, David Belada, Matthew C. Cheung, Olga Samoilova, Cheolwon Suh, Jessica Vermeulen, Louis M. Staudt, Jodi Carey, Catherine Thieblemont, Peter Johnson, C.S. Chiattone, Ulrich Dührsen, Grace Liu, Wyndham H. Wilson, Steven Sun, Jun Zhu
Publikováno v:
Journal of Clinical Oncology. 37:1285-1295
60th Annual Meeting of the American-Society-of-Hematology (ASH) -- DEC 01-04, 2018 -- San Diego, CA Jurczak, Wojciech/0000-0003-1879-8084; Johnson, Peter/0000-0003-2306-4974; ZINZANI, PIER LUIGI/0000-0002-2112-2651; Leppa, Sirpa/0000-0002-8265-511X W
Autor:
Yunhai Li, Kuaile Zhao, Chaoyang Wu, Yun Chen, Saiquan Lu, Jiancheng Li, Zhengfei Zhu, Huarong Tang, Min Fan, Huixun Jia, Jinjun Ye, Ling Li, Jialiang Zhou, Yi Xia, Weixin Zhao, Zhen Zhang, Qin Lin
Publikováno v:
Journal of Clinical Oncology
PURPOSE This trial aimed to assess the efficacy and safety of the paclitaxel plus fluorouracil regimen versus the cisplatin plus fluorouracil regimen in definitive concurrent chemoradiotherapy (dCRT) in patients with locally advanced esophageal squam
Autor:
Sundar Jagannath, Luciano J. Costa, Cassandra Choe-Juliak, A. Keith Stewart, Divaya Bhutani, Ravi Vij, Jeffrey A. Zonder, Jean Richard Saint-Martin, Dan T. Vogl, Craig E. Cole, David Dingli, Rafat Abonour, Michael Kauffman, Rafael Fonseca, Ajay K. Nooka, Sharon Shacham, Terri L. Parker, Robert F. Cornell, Rachid Baz, James E. Hoffman, David Kaminetzky, David S. Siegel, Andrew Yee, Gregory J. Ahmann, Carla Picklesimer, Ilsel Lopez, Joshua R. Richter, Ajai Chari, Carol Ann Huff, Andrzej Jakubowiak, Gary J. Schiller, Scott Van Wier
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 36, iss 9
Purpose Selinexor, a first-in-class, oral, selective exportin 1 (XPO1) inhibitor, induces apoptosis in cancer cells through nuclear retention of tumor suppressor proteins and the glucocorticoid receptor, along with inhibition of translation of oncopr